HIPK2 and cancer: While the removal of its C-terminal fragment is not required for the kinase activity of HIPK2 per se, HIPK2 cleavage leads to enhanced tumor-suppressive p53 response and apoptosis in cancer cells (9–11) and interferon-stimulated antiviral response in peritoneal macrophages (12).